Under construction – not a live service
Sign in
Enrolling by invitationPhase 2/3

Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu

Key facts

Phase
Phase 2/3

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Gadjah Mada University
Trial code
NCT07183215
Record updated
19 September 2025
Original description
The goal of this clinical trial is to learn if Curcuminoid Standardized Turmeric Capsules works to treat Osteoarthritis Genu in adults. It will also learn about the safety of Curcuminoid Standardized Turmeric Capsules. The main questions it aims to answer are:Read full original descriptionShow less

The goal of this clinical trial is to learn if Curcuminoid Standardized Turmeric Capsules works to treat Osteoarthritis Genu in adults. It will also learn about the safety of Curcuminoid Standardized Turmeric Capsules. The main questions it aims to answer are:

* Does Curcuminoid Standardized Turmeric Capsules lower the pain, TNF-Alpha, Interleukin-1 and CRP in the blood? * What medical problems do participants have when taking Curcuminoid Standardized Turmeric Capsules? Researchers will compare Curcuminoid Standardized Turmeric Capsules to a placebo to see if Curcuminoid Standardized Turmeric Capsules works to treat Osteoarthritis Genu.

Participants will:

* Take Curcuminoid Standardized Turmeric Capsules or a placebo every day for 3 weeks * Visit the clinic once every week for checkups and tests * Keep a diary of their symptoms and the number of times they use a rescue paracetamol

Inclusion: Clinical diagnosis of Osteoarthritis which confirmed by physical examination and x-rays; Experience pain with a Numeric Rating scale of 1-7; Must be able to swallow capsules; Must be able to carry out mobility without assistance or with minimal assistance.

Exclusion: Undergoing joint replacement therapy; Parkinson's disease; Dementia disease; Psychosis disease; Cancer; Rheumatic diseases other than Osteoarthritis (rheumatoid arthritis); Analgesic dependent disease; Fractures; Joint dislocations.

ClinicalTrials.gov NCT07183215